Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Tamami Yoshitama"'
Autor:
Shin-ya Kawashiri, Yushiro Endo, Ayako Nishino, Momoko Okamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Toshiyuki Aramaki, Yukitaka Ueki, Tamami Yoshitama, Nobutaka Eiraku, Naoki Matsuoka, Akitomo Okada, Keita Fujikawa, Hiroaki Hamada, Shuji Nagano, Yoshifumi Tada, Atsushi Kawakami
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background To evaluate the effect of treatment on serum bone biomarkers and explore whether serum bone biomarkers are associated with therapeutic response in rheumatoid arthritis (RA) patients treated with abatacept. Methods We enrolled 59 R
Externí odkaz:
https://doaj.org/article/b8e31628dec64b3a98a9239993ef96f6
Autor:
Yushiro Endo, Shin-ya Kawashiri, Shimpei Morimoto, Ayako Nishino, Momoko Okamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Yukitaka Ueki, Tamami Yoshitama, Nobutaka Eiraku, Naoki Matsuoka, Akitomo Okada, Keita Fujikawa, Hiroaki Hamada, Tomomi Tsuru, Shuji Nagano, Yojiro Arinobu, Toshihiko Hidaka, Yoshifumi Tada, Atsushi Kawakami
Publikováno v:
Immunological Medicine, Vol 43, Iss 3, Pp 115-120 (2020)
To compare therapeutic efficacy of tumour necrosis factor inhibitor (TNFi) cyclers and non-TNFi switchers in patients with rheumatoid arthritis (RA) having inadequate response to previous TNFis (TNF-IR patients) using composite measures including ima
Externí odkaz:
https://doaj.org/article/23ec891b9bf14caa82c3ea1a5219dde6
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Objectives To compare effectiveness between tofacitinib and tocilizumab treatments for biological disease-modifying antirheumatic drug (bDMARD)-naïve patients or previous bDMARD-failure patients with active rheumatoid arthritis (RA) refractory to me
Externí odkaz:
https://doaj.org/article/924ec22c92fa4c4592e50ed53483fdca
Autor:
Shunsuke Mori, Tamami Yoshitama, Toshihiko Hidaka, Fumikazu Sakai, Mizue Hasegawa, Yayoi Hashiba, Eiichi Suematsu, Hiroshi Tatsukawa, Akinari Mizokami, Shigeru Yoshizawa, Naoyuki Hirakata, Yukitaka Ueki
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179179 (2017)
OBJECTIVE:Knowing the risk of hospitalized infection associated with individual biological agents is an important factor in selecting the best treatment option for patients with rheumatoid arthritis (RA). This study examined the comparative risk of h
Externí odkaz:
https://doaj.org/article/f271fc6f0eee48139f9336979bf3049b
Autor:
Shunsuke Mori, Michihiro Hidaka, Toshiro Kawakita, Toshihiko Hidaka, Hiroyuki Tsuda, Tamami Yoshitama, Kiyoshi Migita, Yukitaka Ueki
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0154744 (2016)
OBJECTIVE:Severe myelosuppression is a serious concern in the management of rheumatic disease patients receiving methotrexate (MTX) therapy. This study was intended to explore factors associated with the development of MTX-related myelosuppression an
Externí odkaz:
https://doaj.org/article/27bf2ef4b4e14bbb947572f0abeef012
Autor:
Takanori, Azuma, Kenta, Misaki, Makio, Kusaoi, Yoko, Suzuki, Shinji, Higa, Yoshitaka, Kumon, Tamami, Yoshitama, Taio, Naniwa, Shinsuke, Yamada, Tadashi, Okano, Kimihiko, Takeuchi, Kei, Ikeda, Kenshi, Higami, Masayuki, Inoo, Tetsuji, Sawada, Chonte, Kang, Masatoshi, Hayashi, Yuko, Nagaya, Takafumi, Hagiwara, Eisuke, Shono, Shinkichi, Himeno, Eiichi, Tanaka, Eisuke, Inoue, Yuri, Yoshizawa, Michiaki, Kadode, Hisashi, Yamanaka, Masayoshi, Harigai
Publikováno v:
Modern Rheumatology. 33:271-278
Objectives We performed post-hoc analyses of the ORIGAMI study to investigate whether concomitant methotrexate (MTX) influences the clinical outcomes of abatacept in biologic-naïve patients with rheumatoid arthritis. Methods Enrolled patients (n = 3
Autor:
Yushiro Endo, Tomohiro Koga, Toshihiko Hidaka, Ayako Nishino, Remi Sumiyoshi, S.-Y. Kawashiri, Yojiro Arinobu, Akitomo Okada, Katsuhiro Ichinose, K. Fujikawa, Hideki Nakamura, Yoshifumi Tada, Tomomi Tsuru, Naoki Matsuoka, Mami Tamai, Shinya Nishihata, Hiroaki Hamada, H. Otsubo, Tamami Yoshitama, M. Nawata, S. Tsuji, Takashi Igawa, H. Takaoka, Nobutaka Eiraku, Momoko Okamoto, Toru Michitsuji, Toshimasa Shimizu, A. Kawakami, Yukitaka Ueki, Naoki Iwamoto, Tomoki Origuchi, T. Tomokawa, Yoshika Tsuji
Publikováno v:
Scandinavian Journal of Rheumatology. 51:259-267
This study investigated the effectiveness of treatment with Janus kinase (JAK) inhibitors in rheumatoid arthritis (RA) assessed by ultrasonography (US) activity, and the influence of patient characteristics and previous treatments.This prospective st
Autor:
Shunsuke Mori, Yukitaka Ueki, Tomoya Miyamura, Koji Ishii, Toshihiko Hidaka, Tamami Yoshitama, Kazuyoshi Nakamura, Yasuo Suenaga
Publikováno v:
Modern Rheumatology.
Objectives The aim is to evaluate outcomes and risk factors for death in patients with rheumatoid arthritis (RA) who developed Pneumocystis pneumonia (PCP). Methods We included RA patients who were diagnosed with PCP at seven participating community
Autor:
Tamami Yoshitama, Tomohiro Koga, Remi Sumiyoshi, S.-Y. Kawashiri, Mami Tamai, Naoki Matsuoka, Katsuhiro Ichinose, Nobutaka Eiraku, Takashi Igawa, Yoshifumi Tada, Tomoki Origuchi, Yojiro Arinobu, Tomomi Tsuru, H. Otsubo, S. Tsuji, Momoko Okamoto, A. Kawakami, Akitomo Okada, Naoki Iwamoto, K. Fujikawa, Hiroaki Hamada, Yukitaka Ueki, Hideki Nakamura, Yushiro Endo, H. Takaoka, Toshihiko Hidaka, Shuji Nagano, Ayako Nishino, Toshimasa Shimizu
Publikováno v:
Scandinavian Journal of Rheumatology. 50:436-441
Objectives: Using multicentre ultrasound (US) cohort data among patients with rheumatoid arthritis (RA), we aimed to identify baseline factors that permit differentiation between two patient cohort...
Autor:
Tomomi Tsuru, Tamami Yoshitama, Toshimasa Shimizu, Shinpei Morimoto, Momoko Okamoto, Shuji Nagano, Naoki Matsuoka, Ayako Nishino, Naoki Iwamoto, Kunihiro Ichinose, Remi Sumiyoshi, Akitomo Okada, K. Fujikawa, S. Tsuji, Ayuko Takatani, Yojiro Arinobu, Tomoki Origuchi, Mami Tamai, Yoshifumi Tada, S.-Y. Kawashiri, Hiroaki Hamada, Yushiro Endo, Toshihiko Hidaka, Tomohiro Koga, A. Kawakami, Takashi Igawa, Hideki Nakamura, Yukitaka Ueki, Nobutaka Eiraku
Publikováno v:
Scandinavian Journal of Rheumatology. 50:15-19
Objective: To determine whether the positivity of baseline anti-Ro/Sjögren’s syndrome antigen A (SSA) antibodies influences the response to abatacept, we compared therapeutic responses between anti-Ro/SSA antibody-negative and -positive patients w